That’s a wrap for 2025! 🎁 Proud of the work we’ve done with our team this year. Time for a well-deserved break. Happy holidays 🎄! Looking forward to a productive 2026! #KroonLab #EndothelialCells #CardiovascularDisease #ImmunoMetabolism @amsterdamumc

3/3 3- https://t.co/2C3UK4V1Gg This study from @KroonLab shows its not "just" OxPL that can lead to Lp(a)-mediated inflammation, but also diacylglycerol and lysophosphatidic acid.

It's time for a Wine & Science session. If you are interested in immunometabolism and endothelial dysfunction, drop by the poster #011 🔬🍷 @KroonLab #EASCongress2023 #MyEAS23

In recent weeks, our focus has been on the EAS Congress and the new Consensus Statement, but we mustn't forget about our recent AtheroTalk episodes. One of them addresses the question: How do you build confidence and momentum early in your research career? Prof. @KroonLab shares

We are going to trade in our lab coats for Christmas sweaters - we wish you all you happy holidays! ✨

Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype 🔗 https://t.co/6vtyEARiVM @society_eas @atherosociety @KroonLab @mm0kry @ELS_Cardiology #EASSoMe #CvPrev

What do you know about #Lpa? Discover the ground-breaking insights into #Lpa's complex atherogenicity in the latest study led by @DzoboKim from the @KroonLab, unveiling the significant impact of #Lpa-associated diacylglycerols and lysophosphat... @Lpa_doc https://t.co/BsX3XxwHLI

Cardiovascular risk in ANCA-associated vasculitis: monocyte phenotyping reveals distinctive signatures between serological subsets 🔗 https://t.co/4UZerVpqPq @HanfordKatie @Neele_AE @LiffertVogt @KroonLab @HilhorstMarc @society_eas @ELS_Cardiology #CvPrev #EASSoMe

The distinct inflammatory and histological features observed in carotid plaques among 👫 w/ hsCRP levels ≥2 mg/L underscore the utility of hsCRP as a potent identifier for patients harboring high-risk plaques 🔗 https://t.co/6vtyEARiVM @society_eas @KroonLab @mm0kry

Carotid endarterectomy patients with elevated hsCRP levels have an adverse and pro-inflammatory plaque phenotype 🔗 https://t.co/6vtyEAQL6e @society_eas @KroonLab @mm0kry @atherosociety @ELS_Cardiology #EASSoMe

It was a pleasure presenting our work on the pathophysiology of Lp(a) in ASCVD and AVS at #ISFA2025 in Bangkok. What a great conference with fantastic colleagues it was!

These findings highlight changes in monocyte subset composition and activation, but not in the intrinsic migration capacity of AAV monocytes 👇 🔗 https://t.co/4UZerVpqPq @HanfordKatie @Neele_AE @LiffertVogt @KroonLab @HilhorstMarc @society_eas @ELS_Cardiology #EASSoMe #CvPrev

Excited for the start of @IVBM2024 in Amsterdam - looking forward to some fascinating talks!! If you are interested in #metabolism and blood pressure come to my short talk tomorrow in Session 6: Metabolic targeting of vascular remodeling. Chaired by @debocklab @KroonLab

Last Summer School Activity of PhenolAcTwin: We are focusing on “Investigating two-way interactions between dietary polyphenols and the gut microbiome using colon models and LC-MS” Special thanks to #KroonLab. for this great event…

Great catching up with some of my favorite people @PGolforoush and @KroonLab at #EASCongress2025! 🎉 Don’t miss Episode 12 of #AtheroTalk featuring a fascinating conversation with Prof. Jeffrey Kroon. @society_eas @EASCongress #EASYoungFellows

Starting Grant @ERC_Research voor twee onderzoekers @amsterdamumc: Jeffrey Kroon @KroonLab en Marten Hoeksema. Van harte gefeliciteerd🎉!

"I'm absolutely delighted that we have this opportunity to remain part of this programme and work with European countries and go for joint funding." 🌍 💬 Our Group Leader Dr Paul Kroon @KroonLab responds to the #Horizon announcement in @BBCNews https://t.co/TgvFMxfZqx

@ATHjournal @society_eas @KroonLab @mm0kry @atherosociety @ELS_Cardiology Absolutely fascinating study! The link between elevated hsCRP levels and the adverse, pro-inflammatory plaque phenotype raises important questions. Could targeting hsCRP potentially improve patient outcomes? This finding might lead us to re-evaluate current postoperative

@ATHjournal @HanfordKatie @Neele_AE @LiffertVogt @KroonLab @HilhorstMarc @society_eas @ELS_Cardiology These findings are a compelling insight into the role of monocyte subsets in AAV. Understanding how these subsets change could have implications for therapeutic strategies targeting atherosclerosis. What are your thoughts on how this could influence future research directions or